Article
Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration.
EBioMedicine - 1 Feb 2020
Wert Katherine J, Velez Gabriel, Kanchustambham Vijaya L, Shankar Vishnu, Evans Lucy P, Sengillo Jesse D, Zare Richard N, Bassuk Alexander G, Tsang Stephen H, Mahajan Vinit B
Abstract excerpt
BACKGROUND: Neurodegenerative diseases are incurable disorders caused by progressive neuronal cell death. Retinitis pigmentosa (RP) is a blinding neurodegenerative disease that results in photoreceptor death and progresses to the loss of the entire retinal network. We previously found that proteomic analysis of the adjacent vitreous served as way to indirectly biopsy the retina and identify changes in the retinal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
